Related Experiment Video

Updated: May 13, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

[Clinical features and outcome of community-acquired methicillin-resistant Staphylococcus aureus pneumonia]

Mora Obed1, Carolina García-Vidal2, Pedro Pessacq1

  • 1Servicio de Enfermedades Infecciosas, Hospital Rodolfo Rossi, La Plata, Argentina.

Enfermedades Infecciosas Y Microbiologia Clinica
|March 12, 2013
PubMed
Abstract

Insights

Community-acquired pneumonia (CAP) caused by methicillin-resistant Staphylococcus aureus (MRSA) leads to high mortality, particularly in young, healthy individuals with severe lung complications. Early suspicion and treatment are crucial for better outcomes in high-prevalence areas.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Epidemiology

Context:

  • Community-acquired pneumonia (CAP) due to methicillin-resistant Staphylococcus aureus (MRSA) presents distinct epidemiological and clinical challenges.
  • Geographic variations in community-acquired MRSA (CA-MRSA) prevalence influence infection patterns.

Purpose:

  • To delineate the epidemiological and clinical characteristics of MRSA-CAP.
  • To compare treatment and prognosis of MRSA-CAP across two regions with differing CA-MRSA frequencies.
  • To identify key indicators for suspecting MRSA-CAP.

Summary:

  • An observational study identified 16 MRSA-CAP cases between 2008-2012 in Argentina and Spain.
  • MRSA was a rare cause of CAP (0.08%-2.7%), predominantly affecting young, healthy individuals.
  • Frequent findings included multilobar infiltrates, cavitation, positive blood cultures, and high early (19%) and 30-day (25%) mortality rates.

Impact:

  • MRSA-CAP is associated with significant morbidity and mortality, often driven by septic shock and respiratory failure.
  • Clinical suspicion should be heightened in high CA-MRSA prevalence areas, especially for young patients with cavitary multilobar pneumonia.
  • Early recognition and intervention are critical due to the high risk of rapid deterioration and early death.
Keywords:
Community-acquired pneumoniaMethicillin-resistant Staphylococcus aureusNeumonía adquirida en la comunidadStaphylococcus aureus resistente a la meticilinaVancomicinaVancomycin

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...